TABLE OF CONTENTS 



Page 



PREFACE 1 



INTRODUCTION 3 



PROCEDURES FOR ORDERING GENETIC MUTANT CULTURES 5 



REQUIREMENTS 5 



PROCEDURE 5 



ADDRESS 5 



FEES 6 



SHIPPING CHARGES 6 



HOW SHIPPED 7 



DESCRIPTIVE DATA 7 



REQUEST FOR CITATION AND REPRINTS 8 



PUBLICATION OF DESCRIPTIVE ARTICLES ON CELL CULTURES 



STORED IN THE REPOSITORY 8 



ASSURANCE FORM 9 



AGREEMENT ON LYMPHOID AND VIRUS TRANSFORMED CELLS 10 

 HUMAN GENETIC MUTANT CELL REPOSITORY MINIMUM SAFETY GUIDELINES 

 RECOMMENDED FOR WORKING WITH LYMPHOID AND VIRUS TRANSFORMED 



HUMAN CELL LINES 12 



SUPERVISION 12 



PERSONNEL PRACTICES 13 



PHYSICAL CONTROL PRACTICES 14 



SUBMISSION OF SPECIMENS TO THE REPOSITORY 16 



SUBMISSION SHEET 18 

 EXPLANATION OF THE CODE FOR RECORDING DATA IN THE COLUMNS OF 



THE CATALOG 23 



HUMAN FIBROBLAST CULTURES WITH BIOCHEMICAL MUTANT CONDITIONS 26 



DISORDERS OF AMINO ACID METABOLISM 26 



Alkaptonuria 26 



Argininemia 26 



Argininosuccinicaciduria 26 



Citrullinuria (Citrullinemia) 26 



Cystinosis 26 



Type I - Infantile 26 



Type III - Adult 27 



Type Unclassified 27 



Homocystinuria (Cystathionine Synthase Deficiency) 27 



Hyperglycinemia, Non-Ketotic 29 



Hypermethioninemia 29 



Hyperphenylalanineraia 29 



Isovalericacidemia 29 



Maple Syrup Urine Disease (Branched-Chain Ketoaciduria) 29 



Methylmalonicaciduria 30 



Phenylketonuria 30 



Propionicacidemia (Hyperglycinemia with Ketoacidosis & 



Leukopenia) 31 



Tyrosinemia 31 



